Private Equity

We help the people of today, build the companies of tomorrow.
Private Equity

We help the people of today, build the companies of tomorrow.
Private Equity

We help the people of today, build the companies of tomorrow.
Private Equity

We help the people of today, build the companies of tomorrow.

Our Approach

Wille Finance provides capital, operational experience and a network to both growth companies and established businesses looking for a strong financial partner. Our mission is to help organisations become successful and enduring businesses.

Wille Finance is defined by respect and trust for the entrepreneur and the company; we know what it’s like to be in the entrepreneur’s shoes. The team is composed of former founders / managers who have domain expertise ranging from industrial management through ICT to Life-Science and banking industry.

Our Focus

Early & Late Stage

Stage

Early Stage
Venture & Growth
Late Stage
Small & Mid Cap

Geography

Early Stage
Europe
Late Stage
DACH

Industry

Early Stage
Life Science / ICT
Late Stage
Buy & Build

Ticket

Early Stage
CHF 500k - 10 Mio
Late Stage
CHF 5 - 20 Mio

WHO WE ARE

OUR PHILOSOPHY

Long-Term

As a multi-family office, Wille Finance has a long term investment approach, with no pressure to exit. We have the financial capacity to be an anchor investor over several investment rounds.

Loyal Partner

We see an investment as a partnership both ways – we are committed to support a portfolio company with capital, our experience and network.

Entrepreneurial Spirit

Our passion is to help entrepreneurs to build great companies. We are fast, lean and clear in our decisions.

Our Portfolio

An overview of our current and past investments
Tolremo Logo

Tolremo

Tolremo engages in the discovery and development of molecule drugs targeting drug resistance in cancer therapy.
Raziel Therapeutics Logo
Raziel Therapeutics is developing a proprietary new drug for aesthetic applications, and fat disorders with a single injection treatment into...
Redbiotec Logo
Redbiotec develops immunotherapies against Herpes and Cancer based on best-in-class proteins and microorganisms.
Spiral Therapeutics Logo
Spiral is a clinical stage company focused on the development of first-in-class therapies to target hearing loss and other inner...
T3 Pharma Logo
T3 is a pre-clinical company working to advance new generation therapies for cancer patients using live bacteria.
Tolremo Logo
Tolremo engages in the discovery and development of molecule drugs targeting drug resistance in cancer therapy.

Private Equity Numbers

0
Team Members
> 0
Opportunities / Year
0
Portfolio Companies
0
Successful Exits

Partner With Wille Finance

At Wille Finance we are always looking for interesting companies to support. Follow the link below and tell us more about your vision.

Scroll to Top